Cited by 14Renin-Angiotensin System StudiesPeptidase Inhibition and AnalysisProtease and Inhibitor Mechanisms

The DOI matches its Crossref record.

Identification and Characterization of Novel Inhibitors of Mammalian Aspartyl Aminopeptidase

Open access

Abstract

Aspartyl aminopeptidase (DNPEP) has been implicated in the control of angiotensin signaling and endosome trafficking, but its precise biologic roles remain incompletely defined. We performed a high-throughput screen of ∼25,000 small molecules to identify inhibitors of DNPEP for use as tools to study its biologic functions. Twenty-three confirmed hits inhibited DNPEP-catalyzed hydrolysis of angiotensin II with micromolar potency. A counter screen against glutamyl aminopeptidase (ENPEP), an enzyme with substrate specificity similar to that of DNPEP, identified eight DNPEP-selective inhibitors. Structure-activity relationships and modeling studies revealed structural features common to the identified inhibitors, including a metal-chelating group and a charged or polar moiety that could interact with portions of the enzyme active site. The compounds identified in this study should be valuable tools for elucidating DNPEP physiology.

Overview

Integrity signals

Registry

Crossref · 10.1124/mol.114.093070

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LRAT transfers the acyl chain exclusively from phosphatidylcholine onto vitamin A or closely related retinoid-like substrates.

    “Instead, LRAT transfers the acyl chain exclusively from PC onto vitamin A or closely related retinoid-like substrates [40,43].”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 49

  1. Baell, 2010, Observations on screening-based research and some concerning trends in the literature, Future Med Chem, 2, 1529, 10.4155/fmc.10.237 · DOI
  2. Baell, 2010, New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, J Med Chem, 53, 2719, 10.1021/jm901137j · DOI
  3. Balavoine, 2014, Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase A inhibitor prodrug, Clin Pharmacokinet, 53, 385, 10.1007/s40262-013-0125-y · DOI
  4. Bishop, 2009, Brought to life: targeted activation of enzyme function with small molecules, J Chem Biol, 2, 1, 10.1007/s12154-008-0012-4 · DOI
  5. Bodineau, 2008, Aminopeptidase A inhibitors as centrally acting antihypertensive agents, Heart Fail Rev, 13, 311, 10.1007/s10741-007-9077-3 · DOI
  6. Bodineau, 2008, Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension, Hypertension, 51, 1318, 10.1161/HYPERTENSIONAHA.107.098772 · DOI
  7. Brunger, 2007, Version 1.2 of the crystallography and NMR system, Nat Protoc, 2, 2728, 10.1038/nprot.2007.406 · DOI
  8. Cai, 2010, Aspartyl aminopeptidase, encoded by an evolutionarily conserved syntenic gene, is colocalized with its cluster in secretory granules of pancreatic islet cells, Biosci Biotechnol Biochem, 74, 2050, 10.1271/bbb.100349 · DOI
  9. Carlson, 2006, Chemical probes of UDP-galactopyranose mutase, Chem Biol, 13, 825, 10.1016/j.chembiol.2006.06.007 · DOI
  10. Carter, 2001, Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha, Proc Natl Acad Sci USA, 98, 11879, 10.1073/pnas.211178398 · DOI
  11. Chai, 2010, A cell-based assay that targets methionine aminopeptidase in a physiologically relevant environment, Bioorg Med Chem Lett, 20, 2129, 10.1016/j.bmcl.2010.02.052 · DOI
  12. Chaikuad, 2012, Structure of human aspartyl aminopeptidase complexed with substrate analogue: insight into catalytic mechanism, substrate specificity and M18 peptidase family, BMC Struct Biol, 12, 14, 10.1186/1472-6807-12-14 · DOI
  13. Chen, 2012, Insights into substrate specificity and metal activation of mammalian tetrahedral aspartyl aminopeptidase, J Biol Chem, 287, 13356, 10.1074/jbc.M112.347518 · DOI
  14. Forino, 2005, Efficient synthetic inhibitors of anthrax lethal factor, Proc Natl Acad Sci USA, 102, 9499, 10.1073/pnas.0502733102 · DOI
  15. Glenner, 1962, A mammalian peptidase specific for the hydrolysis of N-terminal alpha-L-glutamyl and aspartyl residues, Nature, 194, 867, 10.1038/194867a0 · DOI
  16. Goto, 2006, Enzymatic properties of human aminopeptidase A: regulation of its enzymatic activity by calcium and angiotensin IV, J Biol Chem, 281, 23503, 10.1074/jbc.M603191200 · DOI
  17. Hoffman, 2009, Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5′-phosphate cofactor, J Med Chem, 52, 6032, 10.1021/jm900775q · DOI
  18. Hu, 2008, In situ “click” assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups, Org Lett, 10, 5529, 10.1021/ol802286g · DOI
  19. Larrinaga, 2013, Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer, Transl Res, 162, 297, 10.1016/j.trsl.2013.07.010 · DOI
  20. Li, 2013, Inactivation of Caenorhabditis elegans aminopeptidase DNPP-1 restores endocytic sorting and recycling in tat-1 mutants, Mol Biol Cell, 24, 1163, 10.1091/mbc.e12-10-0730 · DOI
  21. Lindquist, 1969, Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper, Arch Pathol, 87, 370
  22. Marc, 2012, Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats, Hypertension, 60, 411, 10.1161/HYPERTENSIONAHA.112.190942 · DOI
  23. Marchiò, 2004, Aminopeptidase A is a functional target in angiogenic blood vessels, Cancer Cell, 5, 151, 10.1016/S1535-6108(04)00025-X · DOI
  24. Martínez-Martos, 2011, Renin angiotensin system-regulating aminopeptidase activities in serum of pre- and postmenopausal women with breast cancer, Breast, 20, 444, 10.1016/j.breast.2011.04.008 · DOI
  25. Mast, 2014, Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice, J Biol Chem, 289, 3529, 10.1074/jbc.M113.532846 · DOI
  26. Mayas, 2012, Renin-angiotensin system-regulating aminopeptidases in tumor growth of rat C6 gliomas implanted at the subcutaneous region, Anticancer Res, 32, 3675
  27. Mayas, 2012, Influence of chronic ethanol intake on mouse synaptosomal aspartyl aminopeptidase and aminopeptidase A: relationship with oxidative stress indicators, Alcohol, 46, 481, 10.1016/j.alcohol.2011.10.005 · DOI
  28. Mendgen, 2012, Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry, J Med Chem, 55, 743, 10.1021/jm201243p · DOI
  29. Mitsui, 2003, Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice, Mol Med, 9, 57, 10.1007/BF03402108 · DOI
  30. Mucha, 2010, Metallo-aminopeptidase inhibitors, Biochimie, 92, 1509, 10.1016/j.biochi.2010.04.026 · DOI
  31. Nakamura, 2011, Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling, Mol Cell Biol, 31, 3019, 10.1128/MCB.05178-11 · DOI · Paper page
  32. Nanus, 1993, Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A, Proc Natl Acad Sci USA, 90, 7069, 10.1073/pnas.90.15.7069 · DOI
  33. Pérez, 2009, Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma, Head Neck, 31, 1335, 10.1002/hed.21099 · DOI
  34. Powers, 2006, SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase, J Med Chem, 49, 1034, 10.1021/jm050859x · DOI
  35. Rawlings, 2014, MEROPS: the database of proteolytic enzymes, their substrates and inhibitors, Nucleic Acids Res, 42, D503, 10.1093/nar/gkt953 · DOI
  36. Reaux, 1999, Aminopeptidase A inhibitors as potential central antihypertensive agents, Proc Natl Acad Sci USA, 96, 13415, 10.1073/pnas.96.23.13415 · DOI
  37. Simeonov, 2008, Fluorescence spectroscopic profiling of compound libraries, J Med Chem, 51, 2363, 10.1021/jm701301m · DOI
  38. Sivaraman, 2012, X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP, J Mol Biol, 422, 495, 10.1016/j.jmb.2012.06.006 · DOI
  39. Soares, 2010, Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments, Assay Drug Dev Technol, 8, 152, 10.1089/adt.2009.0247 · DOI
  40. Stoermer, 2003, Synthesis and biological evaluation of hydroxamate-based inhibitors of glutamate carboxypeptidase II, Bioorg Med Chem Lett, 13, 2097, 10.1016/S0960-894X(03)00407-4 · DOI
  41. Teuscher, 2007, The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum, J Biol Chem, 282, 30817, 10.1074/jbc.M704938200 · DOI
  42. Tonna, 2008, Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS), Gene, 410, 44, 10.1016/j.gene.2007.11.014 · DOI
  43. Voss, 2003, Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonists, Bioorg Med Chem Lett, 13, 533, 10.1016/S0960-894X(02)00941-1 · DOI
  44. Wang, 2008, Discovery of inhibitors of Escherichia coli methionine aminopeptidase with the Fe(II)-form selectivity and antibacterial activity, J Med Chem, 51, 6110, 10.1021/jm8005788 · DOI
  45. Wilk, 1998, Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase, J Biol Chem, 273, 15961, 10.1074/jbc.273.26.15961 · DOI
  46. Wright, 2003, Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats, Am J Physiol Regul Integr Comp Physiol, 284, R725, 10.1152/ajpregu.00326.2002 · DOI
  47. Wu, 1990, Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family, Proc Natl Acad Sci USA, 87, 993, 10.1073/pnas.87.3.993 · DOI
  48. Yang, 2013, Structural insights into central hypertension regulation by human aminopeptidase A, J Biol Chem, 288, 25638, 10.1074/jbc.M113.494955 · DOI
  49. Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J Biomol Screen, 4, 67, 10.1177/108705719900400206 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Chen, Y., Tang, H., Seibel, W., Papoian, R., Oh, K., Li, X., Zhang, J., Golczak, M., Palczewski, K., & Kiser, P. D.
Affiliations
Case Western Reserve University (US)
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
2014-08
Volume
86
Issue
2
Pages
231-242
ISSN
0026-895X (ISSN-L)
OpenAlex
W2106600857
Cited by
14
References
0
Citations by year
2025: 3 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 1 · 2015: 2
FWCI
0.92
Type
journal article
Language
en
Open access
Locations
  • Molecular Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Case Western Reserve University
  • School of Medicine, Case Western Reserve University
  • National Institutes of Health (EY008061)
  • National Eye Institute (EY-008061, R01EY008061)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
aspartyl aminopeptidase, enzyme inhibitors, glutamyl aminopeptidase, endosomal trafficking, small molecule screening, structure-activity relationship, active site interactions
MeSH terms
Angiotensin II, Animals, Enzyme Inhibitors, Humans, Hydrolysis, Mammals, Structure-Activity Relationship, Spodoptera, Catalytic Domain, Glutamyl Aminopeptidase, Sf9 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review